The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence

@article{Mason2010TheNC,
  title={The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence},
  author={B. Mason and C. Heyser},
  journal={Expert Opinion on Drug Safety},
  year={2010},
  volume={9},
  pages={177 - 188}
}
  • B. Mason, C. Heyser
  • Published 2010
  • Medicine
  • Expert Opinion on Drug Safety
  • Importance to the field: Acamprosate, marketed under the brand name Campral®, (Forest Pharmaceuticals, Inc., Saint Louis, MO, USA; Merck Sante s.a.s., Lyon, France) is an orally administered drug approved in the US and throughout much of the world for treating alcohol dependence. Its safety and efficacy have been demonstrated in a number of clinical trials worldwide and as with all pharmacotherapies for alcoholism, it is used in conjunction with psychosocial interventions. Areas covered in this… CONTINUE READING
    The development of acamprosate as a treatment against alcohol relapse
    • 12
    Alcohol addiction - the safety of available approved treatment options
    • 19
    Alcohol Craving, Glutamate and Acamprosate
    • 1
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 139 REFERENCES
    Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.
    • 122
    Rationale for combining acamprosate and naltrexone for treating alcohol dependence.
    • 21
    Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.
    • 370
    Acamprosate in alcohol dependence: a randomized controlled efficacy study in a standard clinical setting.
    • 37
    • Highly Influential
    Acamprosate in the treatment of alcoholism: mechanisms and perspectives
    • 3
    Acamprosate in the treatment of alcohol dependence
    • 31
    Acamprosate in Alcohol Dependence: Implications of a Unique Mechanism of Action
    • 47